- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
GSK enters India's oncology market, launching precision therapies Jemperli and Zejula for gynaecological cancers. This targets unmet medical needs, reinforcing GSK's specialty portfolio and signaling new growth in a critical segment.
All announcements from GlaxoSmithKline Pharmaceuticals Limited